The DOI matches its Crossref record; 150 of the 152 references it cites were found in a registry or an index; 41 of the 151 sources its claims cite were checked for support.
Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurobehavioral disorders of childhood and can profoundly affect children’s academic achievement, well-being, and social interactions. The American Academy of Pediatrics first published clinical recommendations for evaluation and diagnosis of pediatric ADHD in 2000; recommendations for treatment followed in 2001. The guidelines were revised in 2011 and published with an accompanying process of care algorithm (PoCA) providing discrete and manageable steps by which clinicians could fulfill the clinical guideline’s recommendations. Since the release of the 2011 guideline, the Diagnostic and Statistical Manual of Mental Disorders has been revised to the fifth edition, and new ADHD-related research has been published. These publications do not support dramatic changes to the previous recommendations. Therefore, only incremental updates have been made in this guideline revision, including the addition of a key action statement related to diagnosis and treatment of comorbid conditions in children and adolescents with ADHD. The accompanying process of care algorithm has also been updated to assist in implementing the guideline recommendations. Throughout the process of revising the guideline and algorithm, numerous systemic barriers were identified that restrict and/or hamper pediatric clinicians’ ability to adopt their recommendations. Therefore, the subcommittee created a companion article (available in the Supplemental Information) on systemic barriers to the care of children and adolescents with ADHD, which identifies the major systemic-level barriers and presents recommendations to address those barriers; in this article, we support the recommendations of the clinical practice guideline and accompanying process of care algorithm.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
42 No full text of the sources · 19 Partly supported · 17 Own interpretation · 7 Own method · 5 Supported · 5 Sources not found · 4 Supported so far · 4 Not checked yet · 4 No basis given · 2 Couldn’t confirm · 1 Mixed support · accuracy not yet measured
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Boys are more likely to exhibit externalizing conditions like oppositional defiant disorder or conduct disorder.17,19,20”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > ADHD EPIDEMIOLOGY AND SCOPE
What the sources say
- Disputedcites [17] Elia, 2008, ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents, Child Adolesc Psychiatry Ment Health sourceExperimental — accuracy not yet measured
The Results report no significant sex differences in the diagnostic frequency patterns, including oppositional defiant disorder; the only exception was separation anxiety, which was more common in girls. The paper therefore does not support the claim that boys with ADHD are more likely than girls to have these externalizing conditions. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [19] Cuffe, ADHD and psychiatric comorbidity: functional outcomes in a school-based sample of children [published online ahead of print November 25, 2015], J Atten Disord sourceExperimental — accuracy not yet measured
The Results report that conduct disorder and oppositional defiant disorder were significantly more common among children with ADHD than among children without ADHD at both study sites. They do not report that boys with ADHD were more likely than girls with ADHD to have these conditions; the sex comparison was not supported by the passages found. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [20] Gaub, 1997, Gender differences in ADHD: a meta-analysis and critical review, J Am Acad Child Adolesc Psychiatry source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The majority of both boys and girls with ADHD also meet diagnostic criteria for another mental disorder.17,18”
- Also stated in: § KAS 3 · plain
“The majority of both boys and girls with ADHD also meet diagnostic criteria for another mental disorder.17,18”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > ADHD EPIDEMIOLOGY AND SCOPE
What the sources say
- Partly supportedcites [17] Elia, 2008, ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents, Child Adolesc Psychiatry Ment Health sourceExperimental — accuracy not yet measured
The Results report that 36.3% of the ADHD sample had no additional diagnosis, so a majority had at least one. The paper does not report this proportion separately for boys and girls; its statement that most diagnostic frequency patterns did not differ significantly by sex does not establish a majority in each group. The sample was also a selected clinical cohort. (LLM, conf=0.84)
- Not matchedcites [18] Centers for Disease Control and Prevention (CDC), 2005, Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003, MMWR Morb Mortal Wkly Rep
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § KAS 3 · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“Authors of longitudinal studies have found that ADHD treatments are frequently not maintained over time13 and impairments persist into adulthood.70”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Supportedcites [13] Molina, 2009, The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study, J Am Acad Child Adolesc Psychiatry source
The Discussion reports a dramatic decline in medication adherence as children with ADHD enter adolescence. In this longitudinal study, 62% of children taking medication at the 14-month assessment had stopped by the eight-year follow-up, supporting the claim that treatment is frequently not maintained over time. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“ADHD is a chronic condition; therefore, the PCC should manage children and adolescents with ADHD in the same manner that they would children and youth with special health care needs, following the principles of the chronic care model and the medical home (Table 5).”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Supportedcites [13] Molina, 2009, The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study, J Am Acad Child Adolesc Psychiatry source
The Discussion reports that, eight years after childhood diagnosis, the ADHD group still had substantially higher symptoms and poorer functioning than comparison children, and it recommends long-term monitoring. This supports describing ADHD as a chronic condition, although the paper notes that not every child continued to meet diagnostic criteria. (LLM, conf=0.88)
- Supportedcites [70] Sibley, 2017, Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity, J Child Psychol Psychiatry source
The Discussion (page unavailable) reports that ADHD symptoms persisted into young adulthood in approximately 60% of the childhood ADHD group under the authors’ optimized definition. This supports describing ADHD as a condition that can be chronic; the paper does not say it persists in everyone. The citing sentence’s care-management recommendation is not part of the claim attributed to this source. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“There is evidence that the diagnostic criteria for ADHD can be applied to preschool-aged children.33–39”
- Also stated in: § Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday) · hedged
“A review of the literature, including the multisite study of the efficacy of methylphenidate in preschool-aged children, found that the DSM-5 criteria could appropriately identify children with ADHD.25”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday)
What the sources say
- Not checked — no full text of the sourcecites [33] Lahey, 1998, Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children, J Am Acad Child Adolesc Psychiatry source
- Not checked — no full text of the sourcecites [34] Pavuluri, 1999, Parent reported preschool attention deficit hyperactivity: measurement and validity, Eur Child Adolesc Psychiatry source
- Partly supportedcites [35] Harvey, 2009, Predicting attention-deficit/hyperactivity disorder and oppositional defiant disorder from preschool diagnostic assessments, J Consult Clin Psychol sourceExperimental — accuracy not yet measured
The Abstract reports that early assessments support the validity of ADHD diagnoses in preschool children, and the Discussion says children with ADHD could be distinguished from those with transient problems as early as age 3. The Methods specify that the study used DSM-IV symptom counts, not DSM-5 criteria, so the DSM-5 qualification in the supplied claim is not supported by this source. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [36] Keenan, 2000, More than the terrible twos: the nature and severity of behavior problems in clinic-referred preschool children, J Abnorm Child Psychol source
- Not checked — no full text of the sourcecites [37] Gadow, 2000, Comparison of attention-deficit/hyperactivity disorder symptom subtypes in Ukrainian schoolchildren, J Am Acad Child Adolesc Psychiatry source
- Not checked — no full text of the sourcecites [38] Sprafkin, 2002, A DSM-IV-referenced screening instrument for preschool children: the Early Childhood Inventory-4, J Am Acad Child Adolesc Psychiatry source
- Partly supportedcites [39] Poblano, 2006, ECI-4 screening of attention deficit-hyperactivity disorder and co-morbidity in Mexican preschool children: preliminary results, Arq Neuropsiquiatr sourceExperimental — accuracy not yet measured
The Results report applying DSM-IV ADHD symptom criteria to preschool children, which supports the citing sentence’s general point. The paper does not address DSM-5, as specified in the supplied claim. The Discussion also says that the validity of very early ADHD diagnoses remains open to debate and that screening cannot itself provide a clinical diagnosis. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [25] Evans, 2018, Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder, J Clin Child Adolesc Psychol source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday) · hedged
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“They also have lower educational achievement than those without ADHD73,74 and increased rates of incarceration.75–77”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Not checked — no full text of the sourcecites [75] Barbaresi, 2013, Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study, Pediatrics source
- Could not verifycites [76] Chang, 2016, Association between prescription of major psychotropic medications and violent reoffending after prison release, JAMA sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) mentions ADHD among prisoners, and the Results examine violent reoffending in prisoners with ADHD. Neither compares incarceration rates for people with and without ADHD. Searches for ADHD, imprisonment, and incarceration risk found no passage making that comparison. (LLM, conf=0.76)
- Partly supportedcites [77] Lichtenstein, 2012, Medication for attention deficit-hyperactivity disorder and criminality, N Engl J Med sourceExperimental — accuracy not yet measured
The Results report substantially higher criminal-conviction rates among people with ADHD than among matched general-population controls (36.6% versus 8.9% for men; 15.4% versus 2.2% for women). But the Methods identify conviction as the main outcome; although the study linked to a prison register, these passages do not establish higher incarceration rates. (LLM, conf=0.86)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As in the 2 previous guidelines, this recommendation is based on the evidence that for many individuals, ADHD causes symptoms and dysfunction over long periods of time, even into adulthood.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Partly supportedcites [13] Molina, 2009, The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study, J Am Acad Child Adolesc Psychiatry sourceExperimental — accuracy not yet measured
The Discussion reports that, eight years after childhood treatment, the MTA group still had substantially higher ADHD symptom scores and poorer functioning than former classmates in adolescence. It mentions evidence concerning early adulthood, but this study's follow-up does not establish that its participants' symptoms and dysfunction persisted into adulthood. (LLM, conf=0.86)
- Supportedcites [70] Sibley, 2017, Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity, J Child Psychol Psychiatry source
The Discussion reports that, among participants diagnosed with ADHD in childhood, approximately 60% met the study’s optimized symptom-persistence definition in young adulthood, and 41.1% met both that definition and an impairment criterion. This supports the claim that symptoms and dysfunction persist into adulthood for many individuals; the paper notes that persistence estimates depend on how they are defined. (LLM, conf=0.92)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Authors of longitudinal studies have found that ADHD treatments are frequently not maintained over time13 and impairments persist into adulthood.70”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Supportedcites [70] Sibley, 2017, Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity, J Child Psychol Psychiatry source
The Discussion reports that 41.1% of participants with childhood ADHD met both symptom-persistence criteria and the impairment criterion in young adulthood. The Introduction places the follow-up at a mean age of 24.7 years. These findings support the claim that impairments can persist into adulthood. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Learning and language problems are common comorbid conditions with ADHD.15”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > ADHD EPIDEMIOLOGY AND SCOPE
What the sources say
- Partly supportedcites [15] Mueller, 2012, Examining the comorbidity of language disorders and ADHD, Top Lang Disord sourceExperimental — accuracy not yet measured
The 'LI in Children with ADHD' summary (page not provided) reports high rates of co-occurring language impairment in children with ADHD, supporting the language-problems portion. The passages do not establish that learning problems, as distinct from language problems, are a common comorbid condition. (LLM, conf=0.86)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recent research has established that girls with ADHD are more likely than boys to have a comorbid internalizing condition like anxiety or depression.21”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > ADHD EPIDEMIOLOGY AND SCOPE
What the sources say
- Partly supportedcites [21] Tung, 2016, Patterns of comorbidity among girls with ADHD: a meta-analysis, Pediatrics sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports that girls with ADHD have higher rates of anxiety and depression diagnoses than girls without ADHD, and notes that girls generally have higher rates of internalizing psychopathology than boys. The paper does not establish that girls with ADHD are more likely than boys with ADHD to have a comorbid internalizing condition; its meta-analysis compares girls with and without ADHD. (LLM, conf=0.86)
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Among nonstimulant medications, 1 selective norepinephrine reuptake inhibitor, atomoxetine,99,100 and 2 selective α-2 adrenergic agonists, extended-release guanfacine101,102 and extended-release clonidine,103 have also demonstrated efficacy in reducing core symptoms among school-aged children and adolescents”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD
What the sources say
- Not checked — no full text of the sourcecites [99] Cheng, 2007, Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis, Psychopharmacology (Berl) source
- Not checked — no full text of the sourcecites [100] Michelson, 2002, Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study, Am J Psychiatry source
- Not checked — no full text of the sourcecites [101] Biederman, 2008, A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder, Pediatrics source
- Not checked — no full text of the sourcecites [102] Sallee, 2009, Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder, J Child Adolesc Psychopharmacol source
- Supportedcites [103] Jain, 2011, Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder, J Am Acad Child Adolesc Psychiatry source
Citation 103 is attached to extended-release clonidine, not to the other two medications. The Patient Population section identifies participants aged 6–17, and the Efficacy section reports significantly greater improvement in ADHD symptom scores with extended-release clonidine than with placebo. Page numbers were not available in our copy. (LLM, conf=0.94)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Diminished growth was in the range of 1 to 2 cm from predicted adult height.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Side Effects
What the sources say
- Partly supportedcites [110] Swanson, 2007, Effects of stimulant medication on growth rates across 3 years in the MTA follow-up, J Am Acad Child Adolesc Psychiatry sourceExperimental — accuracy not yet measured
The Clinical Implications section reports an approximately 2 cm height difference after up to three years of stimulant treatment in school-age children. It does not describe that difference as a shortfall from predicted adult height; the Results likewise compare children's heights at 36 months, not adult-height predictions. Page numbers were not available in our copy. (LLM, conf=0.90)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The results of the MTA study were particularly noted among children who were on higher and more consistently administered doses of stimulants.110”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Side Effects
What the sources say
- Partly supportedcites [110] Swanson, 2007, Effects of stimulant medication on growth rates across 3 years in the MTA follow-up, J Am Acad Child Adolesc Psychiatry sourceExperimental — accuracy not yet measured
The Results report a dose-related reduction in relative height, but not weight. They also say the consistently medicated group was already smaller at baseline and did not show a greater decline over time than the inconsistently medicated group. The paper therefore does not establish that growth effects were particularly pronounced with more consistent administration. (LLM, conf=0.87)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Behavioral parent and classroom training are well-established treatments with preadolescent children.25,87,88”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Psychosocial Treatments
What the sources say
- Not checked — no full text of the sourcecites [25] Evans, 2018, Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder, J Clin Child Adolesc Psychol source
- Partly supportedcites [87] Webster-Stratton, 2011, Combining parent and child training for young children with ADHD, J Clin Child Adolesc Psychol sourceExperimental — accuracy not yet measured
The Parent Training Interventions section (page unavailable) describes established efficacy of parent training for ODD and conduct behaviors and refers to effects of behavioral interventions in older children. The Discussion (page unavailable) reports benefits from classroom interventions in prior studies, but the cited paper does not establish that both parent and classroom training are well-established treatments for preadolescent children. (LLM, conf=0.81)
- Not checked — no full text of the sourcecites [88] Shepard, 2009, Preventive intervention for early childhood behavioral problems: an ecological perspective, Child Adolesc Psychiatr Clin N Am source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Overall, behavioral family approaches may be helpful to some adolescents and their families, and school-based training interventions are well established.25,94”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents
What the sources say
- Not checked — no full text of the sourcecites [25] Evans, 2018, Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder, J Clin Child Adolesc Psychol source
- Supportedcites [94] Sibley, 2016, Parent-teen behavior therapy + motivational interviewing for adolescents with ADHD, J Consult Clin Psychol source
The Discussion says the study offers promise for a parent–teen skills-based therapy to engage families and improve symptoms and impairments in adolescents with ADHD. This supports the cautious claim that behavioral family approaches may help some adolescents and their families. (LLM, conf=0.91)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Training approaches that are focused on school functioning skills have consistently revealed benefits for adolescents.95–97”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents
What the sources say
- Not checked — no full text of the sourcecites [95] Evans, 2016, Evaluation of a school-based treatment program for young adolescents with ADHD, J Consult Clin Psychol source
- Not checked — no full text of the sourcecites [96] Langberg, 2018, Overcoming the research-to-practice gap: a randomized trial with two brief homework and organization interventions for students with ADHD as implemented by school mental health providers, J Consult Clin Psychol source
- Partly supportedcites [97] Schultz, 2017, Outcomes for adolescents who comply with long-term psychosocial treatment for ADHD, J Consult Clin Psychol sourceExperimental — accuracy not yet measured
The Methods describe a school-based program targeting organization, study skills, and assignment tracking. The Discussion reports academic benefits, but specifically among adolescents with ADHD who attended at least 80% of sessions; it does not establish consistent benefits for adolescents generally or for training approaches broadly. No page number is available in our copy. (LLM, conf=0.85)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Overall, behavioral family approaches may be helpful to some adolescents and their families, and school-based training interventions are well established.25,94”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents
What the sources say
- Not checked — no full text of the sourcecites [25] Evans, 2018, Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder, J Clin Child Adolesc Psychol source
- Supportedcites [94] Sibley, 2016, Parent-teen behavior therapy + motivational interviewing for adolescents with ADHD, J Consult Clin Psychol source
The Public Health Significance section says adolescent ADHD skills interventions are primarily delivered in schools and have demonstrated efficacy in controlled trials, supporting the school-based part of the sentence. The same section reports reduced home conflict after parent behavior-management training, supporting the qualified statement that behavioral family approaches may help some families. Page numbers were not supplied. (LLM, conf=0.90)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Although it is FDA approved, the efficacy for external trigeminal nerve stimulation (eTNS) is documented by one 5-week randomized controlled trial with just 30 participants receiving eTNS.90”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Psychosocial Treatments
What the sources say
- Partly supportedcites [90] McGough, 2019, Double-blind, sham-controlled, pilot study of trigeminal nerve stimulation for attention-deficit/hyperactivity disorder, J Am Acad Child Adolesc Psychiatry sourceExperimental — accuracy not yet measured
The Abstract (Method) and Method (Study Design) describe a randomized, sham-controlled ADHD trial with four weeks of stimulation followed by one week without treatment. Results (Demographics and Disposition) report 32 participants assigned to active TNS, not 30; 30 were assigned to sham. The paper supports the efficacy finding, but not the claim’s active-group count or its description of a five-week treatment trial. Page numbers are unavailable in our copy. (LLM, conf=0.91)
plainn = 30- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“training interventions are well-established treatments to target disorganization of materials and time that are exhibited by most youth with ADHD; it is likely that they will benefit younger children, as well.25,89”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Psychosocial Treatments
What the sources say
- Not checked — no full text of the sourcecites [25] Evans, 2018, Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder, J Clin Child Adolesc Psychol source
- Partly supportedcites [89] Evans, 2014, Middle school-based and high school-based interventions for adolescents with ADHD, Child Adolesc Psychiatr Clin N Am sourceExperimental — accuracy not yet measured
The Interventions section (page unavailable) describes training adolescents with ADHD to organize materials and manage time, and reports large parent-rated gains from HOPS. But its evidence is limited to modest-sized studies of middle-school adolescents, and the cited passages do not establish that these difficulties occur in most youth with ADHD. Calling the interventions well-established treatments for most youth overstates that evidence. (LLM, conf=0.84)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The Multimodal Treatment of Attention Deficit Hyperactivity Disorder (MTA) study results identified stimulants as having a more persistent effect on decreasing growth velocity compared to most previous studies.110”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Side Effects
What the sources say
- Partly supportedcites [110] Swanson, 2007, Effects of stimulant medication on growth rates across 3 years in the MTA follow-up, J Am Acad Child Adolesc Psychiatry sourceExperimental — accuracy not yet measured
The Discussion reports a stimulant-related reduction in growth velocity that was greatest in the first year, diminished in the second, and absent in the third. It also reports no evidence of growth rebound during continued treatment, contrary to the earlier consensus described in the paper. The claim overstates the comparison: the paper does not establish that the effect was more persistent than in most previous studies, and it cites earlier studies that also found persistent slowing. (LLM, conf=0.83)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Given the risks of driving for adolescents with ADHD, including crashes and motor vehicle violations, special concern should be taken to provide medication coverage for symptom control while driving.79,136,137”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday)
What the sources say
- Partly supportedcites [79] Chang, 2014, Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study, JAMA Psychiatry sourceExperimental — accuracy not yet measured
The Discussion (page not provided) reports an increased rate of serious transport accidents among adults with ADHD, and an association between medication use and fewer accidents among male adults. It does not establish these findings specifically for adolescents or report motor vehicle violations. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [136] Barkley, 2007, A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance, J Safety Res source
- Not checked — no full text of the sourcecites [137] Jerome, 2006, Attention-deficit/hyperactivity disorder (ADHD) and driving risk: a review of the literature and a methodological critique, Curr Psychiatry Rep source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In fact, stimulant medications have not been shown to increase the risk of sudden death beyond that observed in children who are not receiving stimulants.114–118”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Side Effects
What the sources say
- Not checked — no full text of the sourcecites [114] Perrin, 2008, Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder, Pediatrics source
- Not checked — no full text of the sourcecites [115] McCarthy, 2009, Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database, Drug Saf source
- Not checked — no full text of the sourcecites [116] Gould, 2009, Sudden death and use of stimulant medications in youths, Am J Psychiatry source
- Supportedcites [117] Cooper, 2011, ADHD drugs and serious cardiovascular events in children and young adults, N Engl J Med source
The Results report no evidence of increased sudden cardiac death among current ADHD-medication users compared with nonusers. This supports the claim that an increase has not been shown; the paper cautions that its confidence interval cannot rule out an increased risk. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [118] Schelleman, 2011, Cardiovascular events and death in children exposed and unexposed to ADHD agents, Pediatrics source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Throughout the process of revising the guideline and algorithm, numerous systemic barriers were identified that restrict and/or hamper pediatric clinicians’ ability to adopt their recommendations.”
- Also stated in: § Systems Barriers to the Care of Children and Adolescents With ADHD · plain
“There are many system-level barriers that hamper the adoption of the best-practice recommendations contained in the clinical practice guideline and the PoCA.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Systems Barriers to the Care of Children and Adolescents With ADHD · plain
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Note that there is insufficient evidence to recommend diagnosis or treatment for children younger than 4 years (other than parent training in behavior management [PTBM], which does not require a diagnosis to be applied);”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > KAS 1
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The use of neuropsychological testing has not been found to improve diagnostic accuracy in most cases, although it may have benefit in clarifying the child or adolescent’s learning strengths and weaknesses.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > KAS 2
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These publications do not support dramatic changes to the previous recommendations.”
- Also stated in: § INTRODUCTION · plain
“The new research and DSM-5 do not, however, support dramatic changes to the previous recommendations.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: Since the release of the 2011 guideline, the DSM has been revised to the fifth edition, and new ADHD-related research has been published.
- Also stated in: § INTRODUCTION · plain
None of the sources cited for this claim have been checked yet.
In the paper
“Unfortunately, third-party payers seldom pay appropriately for these time-consuming services.5,6”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Systems Barriers to the Care of Children and Adolescents With ADHD
What the sources say
- Not checked — no full text of the sourcecites [5] Pelech, 2019, Medicare advantage and commercial prices for mental health services, Health Aff (Millwood) source
- Not matchedcites [6] Melek, 2017
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Given the nationwide problem of limited access to mental health clinicians,4”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Systems Barriers to the Care of Children and Adolescents With ADHD
What the sources say
- Not matchedcites [4] US Department of Health and Human Services, 2018
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“pediatricians and other PCCs are increasingly called on to provide services to patients with ADHD and to their families.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Systems Barriers to the Care of Children and Adolescents With ADHD
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Normative data are available for the DSM-5–based rating scales for ages 5 years to the 18th birthday.41”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday)
What the sources say
- Not checked — no full text of the sourcecites [41] DuPaul, 2016 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The treatment-related evidence relied on a recent review of literature from 2011 through 2016 by the AHRQ of citations from Medline, Embase, PsycINFO, and the Cochrane Database of Systematic Reviews.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Evidence Review
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Pediatricians and other PCCs should be aware that determining the presence of key symptoms in this age group has its challenges, such as observing symptoms across multiple settings as required by the DSM-5, particularly among children who do not attend a preschool or child care program.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“There is evidence that appropriate diagnosis can be accomplished in the primary care setting for children and adolescents.30,31”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > KAS 1
What the sources say
- Not checked — no full text of the sourcecites [30] Egger, 2006, The epidemiology and diagnostic issues in preschool attention-deficit/hyperactivity disorder: a review, Infants Young Child source
- Not checked — no full text of the sourcecites [31] Wolraich, 2005, Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications, Pediatrics source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In addition, the medical home model has been accepted as the preferred standard of care for children with chronic conditions.69”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Not checked — no full text of the sourcecites [69] Brito, 2008, The enhanced medical home: the pediatric standard of care for medically underserved children, Adv Pediatr source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Hence, the number of children with this condition is far greater than can be managed by the mental health system.4”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > KAS 1
What the sources say
- Not matchedcites [4] US Department of Health and Human Services, 2018
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“They also have lower educational achievement than those without ADHD73,74 and increased rates of incarceration.75–77”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Not checked — no full text of the sourcecites [73] Barbaresi, 2007, Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study, J Dev Behav Pediatr source
- Not checked — no full text of the sourcecites [74] Scheffler, 2009, Positive association between attention-deficit/hyperactivity disorder medication use and academic achievement during elementary school, Pediatrics source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The overall evidence for PTBM among preschoolers is strong.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Recommendations for the Treatment of Children and Adolescents With ADHD: KAS 5a, 5b, and 5c > KAS 5a
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Some training interventions, including social skills training, have not been shown to be effective for children with ADHD.25”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Psychosocial Treatments
What the sources say
- Not checked — no full text of the sourcecites [25] Evans, 2018, Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder, J Clin Child Adolesc Psychol source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Preschool-aged children may experience increased mood lability and dysphoria with stimulant medications.83”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD
What the sources say
- Not checked — no full text of the sourcecites [83] Greenhill, 2006, Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD, J Am Acad Child Adolesc Psychiatry source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“However, because stimulants have been linked to more substantial increases in HR and BP in a subset of individuals (5%–15%), clinicians are encouraged to monitor these vital signs in patients receiving stimulant treatment.112”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Side Effects
What the sources say
- Not checked — no full text of the sourcecites [112] Cortese, 2013, Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents, J Child Psychol Psychiatry source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Stimulant medications have an effect size of around 1.0 (effect size = [treatment M − control M)/control SD]) for the treatment of ADHD.98”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD
What the sources say
- Not checked — no full text of the sourcecites [98] Newcorn, 2008, Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response, Am J Psychiatry source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Of note, adolescents’ reports of their own behaviors often differ from other observers because they tend to minimize their own problematic behaviors43–45”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday)
What the sources say
- Not checked — no full text of the sourcecites [43] Young, 2008, Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder, Adolesc Med State Art Rev source
- Not checked — no full text of the sourcecites [44] Freeman, 2007, Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome, Eur Child Adolesc Psychiatry source
- Not checked — no full text of the sourcecites [45] Riggs, 1998, Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder, J Am Acad Child Adolesc Psychiatry source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Stimulant medications, on average, increase patient heart rate (HR) and blood pressure (BP) to a mild and clinically insignificant degree (average increases: 1–2 beats per minute for HR and 1–4 mm Hg for systolic and diastolic BP).112”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Side Effects
What the sources say
- Not checked — no full text of the sourcecites [112] Cortese, 2013, Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents, J Child Psychol Psychiatry source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Nonetheless, ongoing adherence to psychosocial treatment is a key contributor to its beneficial effects, making implementation of a chronic care model for child health important to ensure sustained adherence.86”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Psychosocial Treatments
What the sources say
- Not checked — no full text of the sourcecites [86] Van Cleave, 2008, Approaching ADHD as a chronic condition: implications for long-term adherence, J Psychosoc Nurs Ment Health Serv source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“An uncommon significant adverse effect of stimulants is the occurrence of hallucinations and other psychotic symptoms.111”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Side Effects
What the sources say
- Not checked — no full text of the sourcecites [111] Mosholder, 2009, Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children, Pediatrics source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Some psychosocial treatments for children and adolescents with ADHD have been demonstrated to be effective for the treatment of ADHD, including behavioral therapy and training interventions.24–26,85”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Psychosocial Treatments
What the sources say
- Not checked — no full text of the sourcecites [24] Pelham, 1998, Empirically supported psychosocial treatments for attention deficit hyperactivity disorder, J Clin Child Psychol source
- Not checked — no full text of the sourcecites [25] Evans, 2018, Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder, J Clin Child Adolesc Psychol source
- Not checked — no full text of the sourcecites [26] Pelham, 2008, Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder, J Clin Child Adolesc Psychol source
- Not checked — no full text of the sourcecites [85] Sonuga-Barke, 2001, Parent-based therapies for preschool attention-deficit/hyperactivity disorder: a randomized, controlled trial with a community sample, J Am Acad Child Adolesc Psychiatry source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“adolescent patients may also attempt to obtain stimulant medication to enhance performance (ie, academic, athletic, etc) by feigning symptoms.48”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday)
What the sources say
- Not checked — no full text of the sourcecites [48] Harrison, 2007, Identifying students faking ADHD: preliminary findings and strategies for detection, Arch Clin Neuropsychol source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“For most adolescents, stimulant medications are highly effective in reducing ADHD’s core symptoms.73”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD
What the sources say
- Not checked — no full text of the sourcecites [73] Barbaresi, 2007, Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study, J Dev Behav Pediatr source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Clinicians should also be aware that adolescents are at greater risk for substance use than are younger children44,45,47”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday)
What the sources say
- Not checked — no full text of the sourcecites [44] Freeman, 2007, Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome, Eur Child Adolesc Psychiatry source
- Not checked — no full text of the sourcecites [45] Riggs, 1998, Clinical approach to treatment of ADHD in adolescents with substance use disorders and conduct disorder, J Am Acad Child Adolesc Psychiatry source
- Not checked — no full text of the sourcecites [47] Kratochvil, 2011, A double-blind, placebo-controlled study of atomoxetine in young children with ADHD, Pediatrics source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Other medications have been used in combination on an off-label basis, with some limited evidence available to support the efficacy and safety of using atomoxetine in combination with stimulant medications to augment treatment of ADHD.128”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Adjunctive Therapy
What the sources say
- Not checked — no full text of the sourcecites [128] Treuer, 2013, A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability, J Child Adolesc Psychopharmacol source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“a secondary analysis of a combined measure of parent and teacher ratings of ADHD symptoms did find a significant advantage for the combination, with a small effect of d = 0.28.140”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Combination Treatments
What the sources say
- Not checked — no full text of the sourcecites [140] Jensen, 2001, Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers, J Dev Behav Pediatr source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In the MTA study, researchers found that although the combination of behavioral therapy and stimulant medication was not significantly more effective than treatment with medication alone for ADHD’s core symptoms, after correcting for multiple tests in the primary analysis,139”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Combination Treatments
What the sources say
- Not checked — no full text of the sourcecites [139] The MTA Cooperative Group, 1999, A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder, Arch Gen Psychiatry source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“For extended-release guanfacine and extended-release clonidine, adverse effects include somnolence, dry mouth, dizziness, irritability, headache, bradycardia, hypotension, and abdominal pain.30,124,125”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Side Effects
What the sources say
- Not checked — no full text of the sourcecites [30] Egger, 2006, The epidemiology and diagnostic issues in preschool attention-deficit/hyperactivity disorder: a review, Infants Young Child source
- Not checked — no full text of the sourcecites [124] Elbe, 2014, Focus on guanfacine extended-release: a review of its use in child and adolescent psychiatry, J Can Acad Child Adolesc Psychiatry
- Not checked — no full text of the sourcecites [125] Croxtall, 2011, Clonidine extended-release: in attention-deficit hyperactivity disorder, Paediatr Drugs source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Maximum doses have not been adequately studied in preschool-aged children.83”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday)
What the sources say
- Not checked — no full text of the sourcecites [83] Greenhill, 2006, Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD, J Am Acad Child Adolesc Psychiatry source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“In some cases, treatment of the ADHD may resolve the comorbid condition. For example, treatment of ADHD may lead to improvement in coexisting aggression and/or oppositional defiant, depressive, or anxiety symptoms.150,151”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KAS 6 > KAS 7
What the sources say
- Not checked — no full text of the sourcecites [150] Pliszka, 2006, The Texas Children’s Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder, J Am Acad Child Adolesc Psychiatry source
- Not checked — no full text of the sourcecites [151] Pringsheim, 2015, The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine, Can J Psychiatry source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Studies indicate that behavioral therapy has positive effects when it is combined with medication for preadolescent children.139”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Combination Treatments
What the sources say
- Not checked — no full text of the sourcecites [139] The MTA Cooperative Group, 1999, A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder, Arch Gen Psychiatry source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Hence, the available evidence regarding dextroamphetamine’s use in preschool-aged children with ADHD is not adequate to recommend it as an initial ADHD medication treatment at this time.80”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday)
What the sources say
- Not checked — no full text of the sourcecites [80] Harstad, 2014, Attention-deficit/hyperactivity disorder and substance abuse, Pediatrics source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Because rebound hypertension after abrupt guanfacine and clonidine discontinuation has been observed,126 these medications should be tapered off rather than suddenly discontinued.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Side Effects
What the sources say
- Not checked — no full text of the sourcecites [126] Vaughan, 2012, Pharmacotherapy of pediatric attention-deficit/hyperactivity disorder, Child Adolesc Psychiatr Clin N Am source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Seven of the 10 single-site studies revealed efficacy for methylphenidate in preschoolers.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday)
What the sources say
- Not checked — no full text of the sourcecites [129] Greenhill, 2008, Attention deficit hyperactivity disorder in preschool children, Child Adolesc Psychiatr Clin N Am source
plaindirectn = 269- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In addition, diversion of ADHD medication (ie, its use for something other than its intended medical purposes) is a special concern among adolescents.135”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday)
What the sources say
- Not checked — no full text of the sourcecites [135] Graff Low, 2002, Illicit use of psychostimulants among college students: a preliminary study, Psychol Health Med source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Atomoxetine has also been linked to growth delays compared to expected trajectories in the first 1 to 2 years of treatment, with a return to expected measurements after 2 to 3 years of treatment, on average.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Side Effects
What the sources say
- Not checked — no full text of the sourcecites [123] Spencer, 2007, Effects of atomoxetine on growth in children with attention-deficit/hyperactivity disorder following up to five years of treatment, J Child Adolesc Psychopharmacol source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Evidence for the use of methylphenidate consists of 1 multisite study of 165 children83 and 10 other smaller, single-site studies ranging from 11 to 59 children, for a total of 269 children.129”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday)
What the sources say
- Not checked — no full text of the sourcecites [83] Greenhill, 2006, Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD, J Am Acad Child Adolesc Psychiatry source
- Not checked — no full text of the sourcecites [129] Greenhill, 2008, Attention deficit hyperactivity disorder in preschool children, Child Adolesc Psychiatr Clin N Am source
plainn = 269- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Children and adolescents with ADHD may be eligible for services as part of a 504 Rehabilitation Act Plan (504 plan) or special education IEP under the “other health impairment” designation in the Individuals with Disability Education Act (IDEA).143”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > School Programming and Supports
What the sources say
- Not matchedcites [143] Davila, 1991, Memorandum on clarification of policy to address the needs of children with attention deficit disorders within general and/or special education
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“Only extended-release guanfacine and extended-release clonidine have evidence supporting their use as adjunctive therapy with stimulant medications sufficient to have achieved FDA approval.127”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Adjunctive Therapy
What the sources say
- Not checked — no full text of the sourcecites [127] Hirota, 2014, Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy, J Am Acad Child Adolesc Psychiatry source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Children in the optimal medication management and combined medication and behavioral management groups underwent a systematic trial with 4 different doses of methylphenidate, with results suggesting that when this full range of doses is administered, more than 70% of children and adolescents with ADHD are methylphenidate responders.140”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KAS 6
What the sources say
- Not checked — no full text of the sourcecites [140] Jensen, 2001, Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers, J Dev Behav Pediatr source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 24
- Probably not a substantial claim. 27
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Treatment discontinuation also places individuals with ADHD at higher risk for catastrophic outcomes, such as motor vehicle crashes78,79; criminality, including drug-related crimes77 and violent reoffending76; depression71; interpersonal issues80; and other injuries.81,82”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Not checked — no full text of the sourcecites [78] Chang, 2017, Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes, JAMA Psychiatry source
- Partly supportedcites [79] Chang, 2014, Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study, JAMA Psychiatry sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [77] Lichtenstein, 2012, Medication for attention deficit-hyperactivity disorder and criminality, N Engl J Med sourceExperimental — accuracy not yet measured
The Abstract Results and Results—Sensitivity analyses report lower criminality rates during ADHD-medication periods, including for substance-related crimes. That supports the criminality and drug-related-crime portion attributed to this paper, but the claim that discontinuation *places* people at higher risk is stronger than the paper’s observational finding; the Discussion cautions that confounding cannot be excluded. The other outcomes in the citing sentence carry separate citations. (LLM, conf=0.85)
- Partly supportedcites [76] Chang, 2016, Association between prescription of major psychotropic medications and violent reoffending after prison release, JAMA sourceExperimental — accuracy not yet measured
The Results and Sensitivity Analyses (page unavailable) associate psychostimulant treatment with lower violent reoffending rates, including among released prisoners diagnosed with ADHD. The claim overstates this as a causal effect of treatment discontinuation in individuals with ADHD generally; the Discussion explicitly says the observational study cannot prove causality. This citation is attached to violent reoffending, not the other listed outcomes. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
Every source the paper cites for this claim was checked and supports it.
In the paper
“As individuals with ADHD enter adolescence, their overt hyperactive and impulsive symptoms tend to decline, whereas their inattentive symptoms tend to persist.13,14”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > ADHD EPIDEMIOLOGY AND SCOPE
What the sources say
- Supportedcites [13] Molina, 2009, The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study, J Am Acad Child Adolesc Psychiatry source
The Discussion reports a decrease in parent- and teacher-rated hyperactivity and impulsivity as the MTA children reached adolescence. The Results (Functioning Relative to the LNCG; page unavailable) report that inattention ratings remained elevated and that inattentive subtype was the most common ADHD diagnosis at eight years. Together, these findings support the stated pattern in this cohort. (LLM, conf=0.87)
- Supportedcites [14] Holbrook, 2016, Persistence of parent-reported ADHD symptoms from childhood through adolescence in a community sample, J Atten Disord source
The Discussion says this study suggests that hyperactive-impulsive symptoms often remit while inattentive symptoms generally persist into adolescence. The Results likewise report declining hyperactive-impulsive symptoms with age and little change in inattentive symptom counts across developmental stages. (LLM, conf=0.94)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It is indicated in prospective studies that patients with ADHD, whether treated or not, are at increased risk for early death, suicide, and increased psychiatric comorbidity, particularly substance use disorders.71,72”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Partly supportedcites [71] Chang, 2016, Medication for attention-deficit/hyperactivity disorder and risk for depression: a nationwide longitudinal cohort study, Biol Psychiatry sourceExperimental — accuracy not yet measured
The Introduction (page not provided) says ADHD is associated with high comorbidity, long-term morbidity and mortality, and that youths with ADHD and comorbid depression face greater risk of adverse outcomes, including suicide. It does not establish increased risk of early death or suicide in patients regardless of treatment status, or identify substance use disorders as a particularly increased comorbidity. The Discussion (page not provided) instead mentions substance use disorder in relation to a possible protective effect of medication. (LLM, conf=0.84)
- Partly supportedcites [72] Biederman, 2009, Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study, Pediatrics sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says ADHD is associated with high rates of psychiatric comorbidity, and the Results (page unavailable) compare subsequent disorders in stimulant-treated and untreated youth. The paper does not report an increased risk of early death or suicide, and substance use disorders were not among the outcomes analyzed. Its results also distinguish treated from untreated youth rather than finding the same psychiatric risk in both groups. (LLM, conf=0.88)
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The American Psychiatric Association developed the DSM-5 using expert consensus and an expanding research foundation.32”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > KAS 2
What the sources say
- Could not verifycites [32] American Psychiatric Association, 2013 sourceExperimental — accuracy not yet measured
The passages labeled 11 September 2026 discuss WHO guidance on depression, not the development of DSM-5. Searches for “DSM-5,” “expert consensus,” and “research foundation” found no passage in our indexed copy addressing the claim. (LLM, conf=0.77)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“The effects diminished by the third year of treatment, but no compensatory rebound growth was observed.110”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Side Effects
What the sources say
- Supportedcites [110] Swanson, 2007, Effects of stimulant medication on growth rates across 3 years in the MTA follow-up, J Am Acad Child Adolesc Psychiatry source
The Abstract reports that stimulant-related decreases in growth rates appeared to reach asymptotes within three years, without evidence of growth rebound. The Discussion likewise finds no support for rebound during continued treatment, although the study did not test rebound after medication withdrawal. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The evidence for this behavioral family approach is mixed and less strong than PTBM with preadolescent children92–94”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents
What the sources say
- Not checked — no full text of the sourcecites [92] Barkley, 1992, A comparison of three family therapy programs for treating family conflicts in adolescents with attention-deficit hyperactivity disorder, J Consult Clin Psychol source
- Partly supportedcites [93] Fabiano, 2016, Efficacy of a family-focused intervention for young drivers with attention-deficit hyperactivity disorder, J Consult Clin Psychol sourceExperimental — accuracy not yet measured
The paper says findings for parent-training programs for adolescents with ADHD are mixed (introductory passage), supporting that part of the claim. The Discussion reports long-lasting gains from behavioral parent training in young children, but it does not directly establish that the overall evidence for the adolescent approach is less strong than for PTBM with preadolescent children. Page numbers are unavailable in our copy. (LLM, conf=0.84)
- Partly supportedcites [94] Sibley, 2016, Parent-teen behavior therapy + motivational interviewing for adolescents with ADHD, J Consult Clin Psychol sourceExperimental — accuracy not yet measured
The Discussion reports mixed results for the adolescent parent–teen intervention: several significant benefits, but no effects on five outcomes and variable maintenance at six months. The paper also describes successful clinic-based approaches for younger children, but it does not directly compare the strength of evidence for adolescent behavioral family therapy with PTBM for preadolescent children (page numbers unavailable in our copy). (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Parent and child and adolescent education is an important component in the chronic illness model to ensure cooperation in efforts to achieve appropriate titration, remembering that the parents themselves may be significantly challenged by ADHD.148,149”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KAS 6
What the sources say
- Not matchedcites [148] Wagner, 1998, Chronic disease management: what will it take to improve care for chronic illness?, Effect Clin Pract
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites [149] Brinkman, 2018, Predictors of medication continuity in children with ADHD, Pediatrics sourceExperimental — accuracy not yet measured
The Discussion (page not available) identifies parent satisfaction with medication information and medication titration as predictors of continuity. A later passage labeled Figure 1 recommends educating families about treatment options and titrating medication. The paper does not establish that parent, child, and adolescent education ensures cooperation with titration, or frame that link as a component of a chronic illness model. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Encouraging strong family-school partnerships helps the ADHD management process, and addressing social determinants of health is essential to these partnerships.145,146”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > School Programming and Supports
What the sources say
- Not checked — no full text of the sourcecites [145] Committee on Pediatric Workforce, 2013, Enhancing pediatric workforce diversity and providing culturally effective pediatric care: implications for practice, education, and policy making, Pediatrics source
- Partly supportedcites [146] Berman, 2018, Screening for poverty and poverty-related social determinants of health, Pediatr Rev sourceExperimental — accuracy not yet measured
The Conclusion (page not available in our copy) urges pediatric providers to address poverty-related social determinants of children’s health and mentions partnerships with community agencies. It does not say that addressing those determinants is essential to family-school partnerships or discuss those partnerships in ADHD management. (LLM, conf=0.78)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Fully addressing systemic barriers requires identifying local, state, and national entities with which to partner to advance solutions and manifest change.156”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > CONCLUSIONS
What the sources say
- Could not verifycites [156] American Academy of Pediatrics, Committee on Child Health Financing, 2012, Scope of health care benefits for children from birth through age 26, Pediatrics sourceExperimental — accuracy not yet measured
The ESSENTIAL BACKGROUND section discusses access to pediatric health benefits and coordination of care, but not partnering with local, state, and national entities to address systemic barriers. Searches for that language and for partnerships or advocacy to overcome barriers found no passage addressing the claim. Page numbers were not available in our copy. (LLM, conf=0.75)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence.
- Could not verify
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The PoCA provides recommendations for implementing the guideline steps, although there is less evidence for the PoCA than for the guidelines.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > PoCA for the Diagnosis and Treatment of Children and Adolescents With ADHD
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The subcommittee members’ potential conflicts were identified and taken into consideration in the group’s deliberations.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > METHODOLOGY
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“There is some evidence that African American and Latino children are less likely to have ADHD diagnosed and are less likely to be treated for ADHD.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Systems Barriers to the Care of Children and Adolescents With ADHD
What the sources say
- Not checked — no full text of the sourcecites [3] Pastor, 2005, Racial and ethnic differences in ADHD and LD in young school-age children: parental reports in the National Health Interview Survey, Public Health Rep source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“No conflicts prevented subcommittee member participation on the guidelines.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > METHODOLOGY
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The procedures recommended in this guideline necessitate spending more time with patients and their families, developing a care management system of contacts with school and other community stakeholders, and providing continuous, coordinated care to the patient and his or her family.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Systems Barriers to the Care of Children and Adolescents With ADHD
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this revised guideline and accompanying PoCA, we recognize that evaluation, diagnosis, and treatment are a continuous process.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > PoCA for the Diagnosis and Treatment of Children and Adolescents With ADHD
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“As noted, ADHD is the most common neurobehavioral disorder of childhood, occurring in approximately 7% to 8% of children and youth.8,18,28,29”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > KAS 1
What the sources say
- Not checked — no full text of the sourcecites [8] Thomas, 2015, Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis, Pediatrics source
- Not checked yetcites [18] Centers for Disease Control and Prevention (CDC), 2005, Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003, MMWR Morb Mortal Wkly Rep
- Not checked — no full text of the sourcecites [28] Visser, 2007, National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder, Pediatrics source
- Not checked yetcites [29] Centers for Disease Control and Prevention (CDC), 2010, Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children–United States, 2003 and 2007, MMWR Morb Mortal Wkly Rep
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Although the chronic illness model has not been specifically studied in children and adolescents with ADHD, it has been effective for other chronic conditions, such as asthma.68”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Not checked yetcites [68] Medical Home Initiatives for Children With Special Needs Project Advisory Committee. American Academy of Pediatrics, 2002, The medical home, Pediatrics
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Under this format, studies were only included in the review when they met a variety of criteria designed to ensure the research was based on a strong methodology that yielded confidence in its conclusions.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Evidence Review
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The subcommittee reached consensus on the evidence, which was then used to develop the clinical practice guideline’s KASs.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Guideline Recommendations and Key Action Statements
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“A variety of other behavioral, developmental, and physical conditions can be comorbid in children and adolescents who are evaluated for ADHD, including emotional or behavioral conditions or a history of these problems.”
- Also stated in: § KAS 3 · plain
“These include but are not limited to learning disabilities, language disorder, disruptive behavior, anxiety, mood disorders, tic disorders, seizures, autism spectrum disorder, developmental coordination disorder, and sleep disorders.50–66”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > KAS 3
What the sources say
- Not checked — no full text of the sourcecites [50] Rowland, 2002, The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view, Ment Retard Dev Disabil Res Rev source
- Not checked — no full text of the sourcecites [51] Cuffe, 2005, Prevalence and correlates of ADHD symptoms in the national health interview survey, J Atten Disord source
- Not checked — no full text of the sourcecites [52] Pastor, 2008, Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006, Vital Health Stat 10
- Not checked — no full text of the sourcecites [53] Biederman, 2004, Further evidence of unique developmental phenotypic correlates of pediatric bipolar disorder: findings from a large sample of clinically referred preadolescent children assessed over the last 7 years, J Affect Disord source
- Not checked — no full text of the sourcecites [54] Biederman, 2005, Absence of gender effects on attention deficit hyperactivity disorder: findings in nonreferred subjects, Am J Psychiatry source
- Not checked — no full text of the sourcecites [55] Biederman, 2008, New insights into the comorbidity between ADHD and major depression in adolescent and young adult females, J Am Acad Child Adolesc Psychiatry source
- Not checked — no full text of the sourcecites [56] Biederman, 2008, Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD, CNS Spectr source
- Not checked — no full text of the sourcecites [57] Crabtree, 2003, Clinical and parental assessment of sleep in children with attention-deficit/hyperactivity disorder referred to a pediatric sleep medicine center, Clin Pediatr (Phila) source
- Not checked — no full text of the sourcecites [58] LeBourgeois, 2004, Snoring, sleep quality, and sleepiness across attention-deficit/hyperactivity disorder subtypes, Sleep source
- Not checked — no full text of the sourcecites [59] Chan, 2002, Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the Medical Expenditure Panel Survey, Arch Pediatr Adolesc Med source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Also stated in: § KAS 3 · plain
In the paper
“The AAP policy statement, “Classifying Recommendations for Clinical Practice Guidelines,” was followed in designating aggregate evidence quality levels for the available evidence (see Fig 1).27”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Guideline Recommendations and Key Action Statements
What the sources say
- Not checked — no full text of the sourcecites [27] American Academy of Pediatrics Steering Committee on Quality Improvement and Management, 2004, Classifying recommendations for clinical practice guidelines, Pediatrics source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, the intervention’s results may inform the subsequent diagnostic evaluation.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Referral to an early intervention program or enrolling in a PTBM program can help provide information about the child’s behavior in other settings or with other observers.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday)
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The guidelines and PoCA underwent extensive peer review by more than 30 internal stakeholders (eg, AAP committees, sections, councils, and task forces) and external stakeholder groups identified by the subcommittee.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Peer Review
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The subcommittee members with the most epidemiological experience assessed the strength of each recommendation and the quality of evidence supporting each draft KAS.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Guideline Recommendations and Key Action Statements
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“PTBM has been modified to include the parents and adolescents in sessions together to develop a behavioral contract and improve parent-adolescent communication and problem-solving (see above).91”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents
What the sources say
- Not checked yetcites [91] Robin, 1989
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In addition, preschool programs (such as Head Start) and ADHD-focused organizations (such as CHADD84) can also provide behavioral supports.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Recommendations for the Treatment of Children and Adolescents With ADHD: KAS 5a, 5b, and 5c > KAS 5a
What the sources say
- Not matchedcites [84] Children and Adults with Attention-Deficit/Hyperactivity Disorder. CHADD. Available at: www.chadd.org. Accessed September 8, 2019
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The evidence is particularly strong for stimulant medications; it is sufficient, but not as strong, for atomoxetine, extended-release guanfacine, and extended-release clonidine, in that order (see the Treatment section, and see the PoCA for more information on implementation).”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Recommendations for the Treatment of Children and Adolescents With ADHD: KAS 5a, 5b, and 5c > KAS 5b
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, the current evidence supporting treatment of ADHD with eTNS is sparse and in no way approaches the robust strength of evidence documented for established medication and behavioral treatments for ADHD; therefore, it cannot be recommended as a treatment of ADHD without considerably more extensive study on its efficacy and safety.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Psychosocial Treatments
plainn = 30- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Children with inattention or hyperactivity/impulsivity at the problem level, as well as their families, may also benefit from the chronic illness and medical home principles.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Inattention or Hyperactivity/Impulsivity (Problem Level)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“Although it was limited to children who had moderate-to-severe dysfunction, the largest multisite study of methylphenidate use in preschool-aged children revealed symptom improvements after PTBM alone.83”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Recommendations for the Treatment of Children and Adolescents With ADHD: KAS 5a, 5b, and 5c > KAS 5a
What the sources say
- Not checked — no full text of the sourcecites [83] Greenhill, 2006, Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD, J Am Acad Child Adolesc Psychiatry source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, the current evidence supporting treatment of ADHD with eTNS is sparse and in no way approaches the robust strength of evidence documented for established medication and behavioral treatments for ADHD; therefore, it cannot be recommended as a treatment of ADHD without considerably more extensive study on its efficacy and safety.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Psychosocial Treatments
plainn = 30- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: There is no long-term safety and efficacy evidence for eTNS.
In the paper
“In addition, the risks of mood and anxiety disorders and risky sexual behaviors increase during adolescence, as do the risks of intentional self-harm and suicidal behaviors.31”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday)
What the sources say
- Not checked — no full text of the sourcecites [31] Wolraich, 2005, Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications, Pediatrics source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, the DSM-PC cannot be used as a definitive source for diagnostic codes related to ADHD and comorbid conditions, although it can be used conceptually as a resource for enriching the understanding of problem-level manifestations.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Inattention or Hyperactivity/impulsivity (Problem Level)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Rests on an assumption: The DSM-PC was published in 1995, and it has not been revised to be compatible with the DSM-5.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As noted, all 4 are common comorbid conditions that affect the treatment approach.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Longer-acting or late-afternoon, short-acting medications may be helpful in this regard.138”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday)
What the sources say
- Not checked — no full text of the sourcecites [138] Cox, 2006, Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder, Pediatrics source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The steps required to sustain appropriate treatments and achieve successful long-term outcomes remain challenging, however.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > CONCLUSIONS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence.
In the paper
“Finally the combination of medication management and behavioral therapy allowed for the use of lower stimulant dosages, possibly reducing the risk of adverse effects.141”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Combination Treatments
What the sources say
- Not checked — no full text of the sourcecites [141] Pelham, 1999, Psychosocial and combined treatments for ADHD, Ment Retard Dev Disabil Res Rev source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Authors of other reports suggest that more than 90% of patients will have a beneficial response to 1 of the psychostimulants if a range of medications from both the methylphenidate and amphetamine and/or dextroamphetamine classes are tried.147”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KAS 6
What the sources say
- Not checked — no full text of the sourcecites [147] Solanto, 1998, Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration, Behav Brain Res source
hedgeddirect- Asserted: fails — The authors may not put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The authors may not put it forward as true. The paper’s conclusions may not depend on it.
In the paper
“Encouraging strong family-school partnerships helps the ADHD management process.142”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > School Programming and Supports
What the sources say
- Not checked — no full text of the sourcecites [142] Homer, 2008, A review of the evidence for the medical home for children with special health care needs, Pediatrics source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Stimulant medications can be effectively titrated on a 7-day basis, but in urgent situations, they may be effectively titrated in as few as 3 days.140”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KAS 6
What the sources say
- Not checked — no full text of the sourcecites [140] Jensen, 2001, Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers, J Dev Behav Pediatr source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The SDBP is developing a guideline to address such complex cases and aid pediatricians and other PCCs to manage these cases; the SDBP currently expects to publish this document in 2019.67”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > IMPLEMENTATION: PREPARING THE PRACTICE
What the sources say
- Not matchedcites [67] Society for Developmental and Behavioral Pediatrics. ADHD special interest group. Available at: www.sdbp.org/committees/sig-adhd.cfm. Accessed September 8, 2019
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Full implementation of the guideline’s KASs, the PoCA, and the recommendations to address barriers to care may require changes in office procedures and the identification of community resources.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > CONCLUSIONS
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Additional adverse effects of atomoxetine include initial somnolence and gastrointestinal tract symptoms, particularly if the dosage is increased too rapidly, and decreased appetite.119–122”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Side Effects
What the sources say
- Not checked — no full text of the sourcecites [119] Garnock-Jones, 2009, Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents, Paediatr Drugs source
- Not checked — no full text of the sourcecites [120] Reed, 2016, The safety of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of research, CNS Drugs source
- Not checked — no full text of the sourcecites [121] Bangs, 2008, Meta-analysis of suicide-related behavior events in patients treated with atomoxetine, J Am Acad Child Adolesc Psychiatry source
- Not checked — no full text of the sourcecites [122] Bangs, 2008, Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder, Drug Saf source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Evidence is clear with regard to the legitimacy of the diagnosis of ADHD and the appropriate diagnostic criteria and procedures required to establish a diagnosis, identify comorbid conditions, and effectively treat with both psychosocial and pharmacologic interventions.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > CONCLUSIONS
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
Since the release of the 2011 guideline, the DSM has been revised to the fifth edition, and new ADHD-related research has been published.
“Since the release of the 2011 guideline, the Diagnostic and Statistical Manual of Mental Disorders has been revised to the fifth edition, and new ADHD-related research has been published.”
The paper relies on this without support.
ADHD is one of the most common neurobehavioral disorders of childhood and can profoundly affect children’s academic achievement, well-being, and social interactions.
“Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurobehavioral disorders of childhood and can profoundly affect children’s academic achievement, well-being, and social interactions.”
The paper relies on this without support.
Symptoms of ADHD occur in childhood, and most children with ADHD will continue to have symptoms and impairment through adolescence and into adulthood.
“Symptoms of ADHD occur in childhood, and most children with ADHD will continue to have symptoms and impairment through adolescence and into adulthood.”
The paper relies on this without support.
The DSM-5 system is used by professionals in psychiatry, psychology, health care systems, and primary care; it is also well established with third-party payers.
“The DSM-5 system is used by professionals in psychiatry, psychology, health care systems, and primary care; it is also well established with third-party payers.”
The paper relies on this without support.
The DSM-5 classification criteria are based on the best available evidence for ADHD diagnosis and are the standard most frequently used by clinicians and researchers to render the diagnosis and document its appropriateness for a given child.
“As with the previous guideline recommendations, the DSM-5 classification criteria are based on the best available evidence for ADHD diagnosis and are the standard most frequently used by clinicians and researchers to render the diagnosis and document its appropriateness for a given child.”
The paper relies on this without support.
There are minimal changes in the specific behaviors from the DSM-IV, on which all the other DSM-based ADHD rating scales obtained normative data.
“There are, however, minimal changes in the specific behaviors from the DSM-IV, on which all the other DSM-based ADHD rating scales obtained normative data.”
The paper relies on this without support.
Both the ADHD Rating Scale-IV and the Conners Rating Scale have preschool-age normative data based on the DSM-IV.
“Both the ADHD Rating Scale-IV and the Conners Rating Scale have preschool-age normative data based on the DSM-IV.”
The paper relies on this without support.
The specific behaviors in the DSM-5 criteria for ADHD are the same for all children younger than 18 years and are only minimally different from the DSM-IV.
“The specific behaviors in the DSM-5 criteria for ADHD are the same for all children younger than 18 years (ie, preschool-aged children, elementary and middle school-aged children, and adolescents) and are only minimally different from the DSM-IV.”
The paper relies on this without support.
PTBM helps parents learn age-appropriate developmental expectations, behaviors that strengthen the parent-child relationship, and specific management skills for problem behaviors.
“This type of training helps parents learn age-appropriate developmental expectations, behaviors that strengthen the parent-child relationship, and specific management skills for problem behaviors.”
The paper relies on this without support.
PTBM has documented effectiveness with a wide variety of problem behaviors, regardless of etiology.
“Clinicians do not need to have made an ADHD diagnosis before recommending PTBM because PTBM has documented effectiveness with a wide variety of problem behaviors, regardless of etiology.”
The paper relies on this without support.
Obtaining teacher reports for adolescents is often more challenging than for younger children because many adolescents have multiple teachers.
“Obtaining teacher reports for adolescents is often more challenging than for younger children because many adolescents have multiple teachers.”
The paper relies on this without support.
An adolescent’s parents may have less opportunity to observe their child’s behaviors than they did when the child was younger.
“Likewise, an adolescent’s parents may have less opportunity to observe their child’s behaviors than they did when the child was younger.”
The paper relies on this without support.
Some problems experienced by children with ADHD are less obvious in adolescents than in younger children because adolescents are less likely to exhibit overt hyperactive behavior.
“Furthermore, some problems experienced by children with ADHD are less obvious in adolescents than in younger children because adolescents are less likely to exhibit overt hyperactive behavior”
The paper relies on this without support.
Variability in ratings is to be expected because adolescents’ behavior often varies between different classrooms and with different teachers.
“Variability in ratings is to be expected because adolescents’ behavior often varies between different classrooms and with different teachers.”
The paper relies on this without support.
Certain substances, such as marijuana, can have effects that mimic ADHD.
“Certain substances, such as marijuana, can have effects that mimic ADHD”
The paper relies on this without support.
Trauma experiences, posttraumatic stress disorder, and toxic stress are additional comorbidities and risk factors of concern.
“Trauma experiences, posttraumatic stress disorder, and toxic stress are additional comorbidities and risk factors of concern.”
The paper relies on this without support.
Teachers, parents, and child health professionals typically encounter children who demonstrate behaviors relating to activity level, impulsivity, and inattention but who do not fully meet DSM-5 criteria.
“Teachers, parents, and child health professionals typically encounter children who demonstrate behaviors relating to activity level, impulsivity, and inattention but who do not fully meet DSM-5 criteria.”
The paper relies on this without support.
These symptoms may suggest other problems that mimic ADHD.
“Also consider that these symptoms may suggest other problems that mimic ADHD.”
The paper relies on this without support.
Behavioral interventions, such as PTBM, are often beneficial for children with hyperactive/impulsive behaviors who do not meet full diagnostic criteria for ADHD.
“Behavioral interventions, such as PTBM, are often beneficial for children with hyperactive/impulsive behaviors who do not meet full diagnostic criteria for ADHD.”
The paper relies on this without support.
The DSM-PC was published in 1995, and it has not been revised to be compatible with the DSM-5.
“The DSM-PC was published in 1995, however, and it has not been revised to be compatible with the DSM-5.”
The paper relies on this without support.
In some cases, the presence of a comorbid condition will alter the treatment of ADHD.
“In some cases, the presence of a comorbid condition will alter the treatment of ADHD.”
The paper relies on this without support.
Available treatments address symptoms and function but are usually not curative.
“Available treatments address symptoms and function but are usually not curative.”
The paper relies on this without support.
This communication can be difficult to achieve.
“This communication can be difficult to achieve and is discussed in both the PoCA and the section on systemic barriers to the care of children and adolescents with ADHD in the Supplemental Information, as is the medical home model.69”
The paper relies on this without support.
PTBM programs for preschool-aged children are typically group programs and, although they are not always paid for by health insurance, they may be relatively low cost.
“PTBM programs for preschool-aged children are typically group programs and, although they are not always paid for by health insurance, they may be relatively low cost.”
The paper relies on this without support.
One evidence-based PTBM, parent-child interaction therapy, is a dyadic therapy for parent and child.
“One evidence-based PTBM, parent-child interaction therapy, is a dyadic therapy for parent and child.”
The paper relies on this without support.
Other stimulant or nonstimulant medications have not been adequately studied in children in this age group with ADHD.
“Other stimulant or nonstimulant medications have not been adequately studied in children in this age group with ADHD.”
The paper relies on this without support.
The medical home and chronic illness approach may be particularly beneficial for parents who also have ADHD themselves.
“The medical home and chronic illness approach may be particularly beneficial for parents who also have ADHD themselves.”
The paper relies on this without support.
Stimulants have a stronger immediate effect on the 18 core symptoms of ADHD than behavior therapy in most studies comparing them.
“Most studies comparing behavior therapy to stimulants indicate that stimulants have a stronger immediate effect on the 18 core symptoms of ADHD.”
The paper relies on this without support.
Parents were more satisfied with the effect of behavioral therapy than with stimulants.
“Parents, however, were more satisfied with the effect of behavioral therapy, which addresses symptoms and functions in addition to ADHD’s core symptoms.”
The paper relies on this without support.
The positive effects of behavioral therapies tend to persist, whereas the positive effects of medication cease when medication stops.
“The positive effects of behavioral therapies tend to persist, but the positive effects of medication cease when medication stops.”
The paper relies on this without support.
Some nonmedication treatments for ADHD-related problems have too little evidence to recommend them or have been found to have little or no benefit, including mindfulness, cognitive training, diet modification, EEG biofeedback, and supportive counseling.
“Some nonmedication treatments for ADHD-related problems have either too little evidence to recommend them or have been found to have little or no benefit. These include mindfulness, cognitive training, diet modification, EEG biofeedback, and supportive counseling.”
The paper relies on this without support.
The suggestion that cannabidiol oil has any effect on ADHD is anecdotal and has not been subjected to rigorous study.
“The suggestion that cannabidiol oil has any effect on ADHD is anecdotal and has not been subjected to rigorous study.”
The paper relies on this without support.
There is no long-term safety and efficacy evidence for eTNS.
“To date, there is no long-term safety and efficacy evidence for eTNS.”
The paper relies on this without support.
Much less research has been published on psychosocial treatments with adolescents than with younger children.
“Much less research has been published on psychosocial treatments with adolescents than with younger children.”
The paper relies on this without support.
Meaningful improvements in functioning have not been reported from cognitive behavioral approaches for adolescents.
“Meaningful improvements in functioning have not been reported from cognitive behavioral approaches.”
The paper relies on this without support.
None of the nonstimulants have FDA approval for use in preschool-aged children.
“None of the nonstimulants have FDA approval for use in preschool-aged children.”
The paper relies on this without support.
The effect size for nonstimulants is 0.7.
“The effect size for stimulants is 1.0 and for nonstimulants is 0.7.”
The paper relies on this without support.
An individual’s response to methylphenidate versus amphetamine is idiosyncratic, with approximately 40% responding to both and about 40% responding to only one.
“An individual’s response to methylphenidate verses amphetamine is idiosyncratic, with approximately 40% responding to both and about 40% responding to only 1.”
The paper relies on this without support.
The subtype of ADHD does not appear to be a predictor of response to a specific agent.
“The subtype of ADHD does not appear to be a predictor of response to a specific agent.”
The paper relies on this without support.
The evidence base supporting norepinephrine reuptake inhibitors and α-2 adrenergic agonists is considerably less than that for stimulants, although it was adequate for FDA approval.
“Norepinephrine reuptake inhibitors and α-2 adrenergic agonists are newer medications, so, in general, the evidence base supporting them is considerably less than that for stimulants, although it was adequate for FDA approval.”
The paper relies on this without support.
Pharmacogenetic tests may cost thousands of dollars and are typically not covered by insurance.
“In addition, these tests may cost thousands of dollars and are typically not covered by insurance.”
The paper relies on this without support.
Stimulants’ most common short-term adverse effects are appetite loss, abdominal pain, headaches, and sleep disturbance.
“Stimulants’ most common short-term adverse effects are appetite loss, abdominal pain, headaches, and sleep disturbance.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Inattention or Hyperactivity/impulsivity (Problem Level)
“The DSM-PC was published in 1995, however, and it has not been revised to be compatible with the DSM-5.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > References
“49. Wolraich ML, Felice ME, Drotar DD. The Classification of Child and Adolescent Mental Conditions in Primary Care: Diagnostic and Statistical Manual for Primary Care (DSM-PC), Child and Adolescent Version. Elk Grove Village, IL: American Academy of Pediatrics; 1996”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185
Self-citationChronic disease management: what will it take to improve care for chronic illness?
Eh, W. (1998) · PubMed · Cited by 2,095
Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
Thomas, R., Sanders, S., Doust, J., Beller, E., & Glasziou, P. (2015) · Pediatrics · doi:10.1542/peds.2014-3482 · Cited by 1,976 · cited 2×
“7 Authors of a recent meta-analysis calculated a pooled worldwide ADHD prevalence of 7.2% among children 8 ; estimates from some community-based samples are somewhat higher, at 8.7% to 15.5%.”
InfluentialMolina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819c23d0 · Cited by 1,182 · cited 1×
“As individuals with ADHD enter adolescence, their overt hyperactive and impulsive symptoms tend to decline, whereas their inattentive symptoms tend to persist.(13,14) Learning and language problems are common comorbid conditions with ADHD.”
Danielson, M. L., Bitsko, R. H., Ghandour, R. M., Holbrook, J. R., Kogan, M. D., & Blumberg, S. J. (2018) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2017.1417860 · Cited by 1,181 · cited 17×
“5,6 To assist pediatricians and other PCCs in overcoming such obstacles, the companion article on systemic barriers to the care of children and adolescents with ADHD reviews the barriers and makes recommendations to address them to enhance care for children and adolescents with ADHD.”
InfluentialGender Differences in ADHD: A Meta-Analysis and Critical Review
GAUB, M., & CARLSON, C. L. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199708000-00011 · Cited by 1,117 · cited 1×
“Boys are more likely to exhibit externalizing conditions like oppositional defiant disorder or conduct disorder.(17,19,20) Recent research has established that girls with ADHD are more likely than boys to have a comorbid internalizing condition like anxiety or depression.”
Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder
Pelham, W. E., & Fabiano, G. A. (2008) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374410701818681 · Cited by 917 · cited 1×
“26 Under this format, studies were only included in the review when they met a variety of criteria designed to ensure the research was based on a strong methodology that yielded con fi dence in its conclusions.”
Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
WILENS, T. E., ADLER, L. A., ADAMS, J., SGAMBATI, S., ROTROSEN, J., SAWTELLE, R., UTZINGER, L., & FUSILLO, S. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815a56f1 · Cited by 824
Research works printed but not linked: 5
- American Academy of Pediatrics Task Force on Mental Health, 2010, Addressing Mental Health Concerns in Primary Care: A Clinician’s Toolkit [CD-ROM]
- Wolraich, 1996, The Classification of Child and Adolescent Mental Conditions in Primary Care: Diagnostic and Statistical Manual for Primary Care (DSM-PC), Child and Adolescent Version
- Robin, 1989, The Guilford Family Therapy Series. Negotiating Parent–Adolescent Conflict: A Behavioral–Family Systems Approach
- Avigan, 2004, Review of AERS Data From Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular SAEs (Including Stroke). Report No. D030403
- Davila, 1991, Memorandum on clarification of policy to address the needs of children with attention deficit disorders within general and/or special education, 261
Cited by
Sorted by citations
Mental Health Surveillance Among Children — United States, 2013–2019
Bitsko, R. H., Claussen, A. H., Lichstein, J., Black, L. I., Jones, S. E., Danielson, M. L., Hoenig, J. M., Davis Jack, S. P., Brody, D. J., Gyawali, S., et al. (2022) · MMWR Supplements · doi:10.15585/mmwr.su7102a1 · Cited by 1,723
Hampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., Avila Edwards, K. C., Eneli, I., Hamre, R., Joseph, M. M., et al. (2023) · Pediatrics · doi:10.1542/peds.2022-060640 · Cited by 1,389
Self-citationLipkin, P. H., Macias, M. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Norwood, K. W., Brei, T. J., Davidson, L. F., Davis, B. E., Ellerbeck, K. A., Houtrow, A. J., Hyman, S. L., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3449 · Cited by 676
Hinshaw, S. P., Nguyen, P. T., O’Grady, S. M., & Rosenthal, E. A. (2022) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13480 · Cited by 424
“Despite evidence-based guidelines prepared by the American Academy of Child and Ado-lescent Psychiatry (Pliszka & AACAP Work Group on Quality Issues, 2007) and the American Academy of Pediatrics (Wolraich et al., 2019) in the United States, and the National Institute for Health and Care Excellence (2019) in the U.K.,…”
BackgroundMethodYeung, A., Ng, E., & Abi-Jaoude, E. (2022) · The Canadian Journal of Psychiatry · doi:10.1177/07067437221082854 · Cited by 355
Metadata
- Authors
- Wolraich, M. L., Hagan, J. F., Allan, C., Chan, E., Davison, D., Earls, M., Evans, S. W., Flinn, S. K., Froehlich, T., Frost, J., Holbrook, J. R., Lehmann, C. U., Lessin, H. R., Okechukwu, K., Pierce, K. L., Winner, J. D., Zurhellen, W., & DISORDER, S. O. C. A. A. W. A.-D.
- Affiliations
- University of Oklahoma (US)
- University of Vermont (US)
- Children's Mercy Hospital (US)
- Boston Children's Hospital (US)
- Children and Adults with Attention Deficit/Hyperactivity Disorder (US)
- University of North Carolina at Chapel Hill (US)
- Ohio University (US)
- American Academy of Pediatrics (US)
- Cincinnati Children's Hospital Medical Center (US)
- American Academy of Family Physicians (US)
- Centers for Disease Control and Prevention (US)
- Vanderbilt University (US)
- uThe Children’s Medical Group, Poughkeepsie, New York;
- Northwestern University (US)
- yAtlanta, Georgia; and
- zHolderness, New Hampshire
- Corresponding author
- Wolraich, Mark L.
- ORCID
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2019-10-01
- Volume
- 144
- Issue
- 4
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- PMC
- PMC7067282
- OpenAlex
- W4213383170
- Semantic Scholar
- b0fa6ec69e8a7d09cc706e5e07fce062628ce632
- Cited by
- 1,562
- References
- 152
- Citations by year
- 2026: 309 · 2025: 288 · 2024: 257 · 2023: 218 · 2022: 202 · 2021: 173 · 2020: 102 · 2019: 8
- FWCI
- 88.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- Funders
- National Institutes of Health (CC999999)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- attention deficit hyperactivity disorder, ADHD treatment, comorbidities, children and adolescents, DSM-5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review